ASO Visual Abstract: Neoadjuvant Therapy Versus Upfront Surgery for Patients with Clinical Stage II and III Esophageal Squamous Cell Carcinoma-A Cost-Effectiveness Analysis

Xing Gao; Yu Wen Wen; Joseph Jan Baptist van Lanschot; Yin Kai Chao

doi:10.1245/s10434-021-11286-2

ASO Visual Abstract: Neoadjuvant Therapy Versus Upfront Surgery for Patients with Clinical Stage II and III Esophageal Squamous Cell Carcinoma-A Cost-Effectiveness Analysis

Xing Gao, Yu Wen Wen, Joseph Jan Baptist van Lanschot, Yin Kai Chao^*

^*Corresponding author for this work

Surgery

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	3656-3657
Number of pages	2
Journal	Annals of Surgical Oncology
Volume	29
Issue number	6
Early online date	12 Feb 2022
DOIs	https://doi.org/10.1245/s10434-021-11286-2
Publication status	Published - Jun 2022

Access to Document

10.1245/s10434-021-11286-2Licence: Unspecified

Cite this

@article{274fdf5475904092904644e51a16f336,

title = "ASO Visual Abstract: Neoadjuvant Therapy Versus Upfront Surgery for Patients with Clinical Stage II and III Esophageal Squamous Cell Carcinoma-A Cost-Effectiveness Analysis",

author = "Xing Gao and Wen, {Yu Wen} and {van Lanschot}, {Joseph Jan Baptist} and Chao, {Yin Kai}",

year = "2022",

month = jun,

doi = "10.1245/s10434-021-11286-2",

language = "English",

volume = "29",

pages = "3656--3657",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer New York",

number = "6",

}

ASO Visual Abstract : Neoadjuvant Therapy Versus Upfront Surgery for Patients with Clinical Stage II and III Esophageal Squamous Cell Carcinoma-A Cost-Effectiveness Analysis. / Gao, Xing; Wen, Yu Wen; van Lanschot, Joseph Jan Baptist et al.

In: Annals of Surgical Oncology, Vol. 29, No. 6, 06.2022, p. 3656-3657.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - ASO Visual Abstract

T2 - Neoadjuvant Therapy Versus Upfront Surgery for Patients with Clinical Stage II and III Esophageal Squamous Cell Carcinoma-A Cost-Effectiveness Analysis

AU - Gao, Xing

AU - Wen, Yu Wen

AU - van Lanschot, Joseph Jan Baptist

AU - Chao, Yin Kai

PY - 2022/6

Y1 - 2022/6

UR - http://www.scopus.com/inward/record.url?scp=85130001690&partnerID=8YFLogxK

U2 - 10.1245/s10434-021-11286-2

DO - 10.1245/s10434-021-11286-2

M3 - Article

C2 - 35152359

AN - SCOPUS:85130001690

VL - 29

SP - 3656

EP - 3657

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 6

ER -

ASO Visual Abstract: Neoadjuvant Therapy Versus Upfront Surgery for Patients with Clinical Stage II and III Esophageal Squamous Cell Carcinoma-A Cost-Effectiveness Analysis

Access to Document

Other files and links

Cite this